LMR Partners LLP - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 53 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
LMR Partners LLP ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
-66.7%
69,5010.0%0.00%
Q2 2022$12,000
-93.8%
69,501
-39.0%
0.00%
-100.0%
Q1 2021$192,000
+1100.0%
113,897
+267.0%
0.01%
+400.0%
Q3 2019$16,000
+33.3%
31,0350.0%0.00%
Q2 2019$12,000
-85.4%
31,035
-80.3%
0.00%
-100.0%
Q2 2017$82,000
-25.5%
157,455
+237.9%
0.01%
-61.5%
Q2 2015$110,000
-22.0%
46,599
+149.1%
0.01%
-31.6%
Q1 2015$141,00018,7100.02%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders